Bio-Techne Corp (TECH) Social Stream
BIO-TECHNE CORP (TECH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIO-TECHNE CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 9 | $600 | $400 | $510.625 | $285.63 | 78.77% |
| 2021-12-01 | 9 | $600 | $400 | $511.875 | $285.63 | 79.21% |
| 2022-02-01 | 9 | $600 | $400 | $506.25 | $285.63 | 77.24% |
| 2022-03-01 | 6 | $600 | $540 | $565 | $285.63 | 97.81% |
| 2022-04-25 | 7 | $600 | $370 | $532.5 | $285.63 | 86.43% |
| 2022-05-05 | 7 | $575 | $370 | $515.833 | $285.63 | 80.59% |
| 2022-06-06 | 7 | $575 | $370 | $506.428 | $285.63 | 77.3% |
| 2022-08-04 | 6 | $580 | $370 | $507.142 | $285.63 | 77.55% |
| 2022-08-05 | 6 | $580 | $370 | $491.428 | $285.63 | 72.05% |
| 2022-09-22 | 6 | $580 | $360 | $490 | $285.63 | 71.55% |
The Trend in the Analyst Price Target
TECH's average price target has moved up $151.44 over the prior 20 months.
Over the past 46 weeks, TECH's average upside potential has been 33.73%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 9 | 600 | 400 | 511.875 | 461.94 | 10.81% |
| 2022-01-07 | 9 | 600 | 400 | 506.250 | 415.28 | 21.91% |
| 2022-02-01 | 9 | 600 | 410 | 542.500 | 401.57 | 35.09% |
| 2022-02-01 | 7 | 600 | 400 | 506.250 | 401.57 | 26.07% |
| 2022-03-01 | 7 | 600 | 540 | 565.000 | 420.18 | 34.47% |
TECH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 5 | 0 | 0 | 1 | 1 | 6 |
The Trend in the Broker Recommendations
TECH's average broker recommendation rating worsened by 0.1 over the prior 123 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TECH as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, BIO-TECHNE CORP's average analyst price target is higher than 1571.72% of them.
- In terms of how BIO-TECHNE CORP fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 262.61% of that group.
- BIO-TECHNE CORP's variance in analysts' estimates is lower than -291.4% of Pharmaceutical Products stocks.
- TECH has a higher upside potential (average analyst target price relative to current price) than 1155.47% of stocks in the large market cap category.
In the Pharmaceutical Products industry, SGEN, RGEN, and QGEN are the three stocks most similar to BIO-TECHNE CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is TECH a Buy, Hold or Sell? See the POWR Ratings now!